Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes

NCT06989723 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Fatty Liver

Interventions

DRUG: Pioglitazone 15 MG [Actos]
DRUG: Empagliflozin 10 MG [Jardiance]
DRUG: Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos]

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]